Earnings results for Alterola Biotech (OTCMKTS:ALTA)
Altabancorp is expected* to report earnings on 10/28/2020 after market close. The report will be for the fiscal Quarter ending Sep 2020. According to Zacks Investment Research, based on 4 analysts’ forecasts, the consensus EPS forecast for the quarter is $0.53. The reported EPS for the same quarter last year was $0.59.
Alterola Biotech last issued its quarterly earnings results on July 29th, 2020. The reported $0.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.08. The firm had revenue of $31.91 million for the quarter, compared to the consensus estimate of $30.39 million. Alterola Biotech has generated $0.00 earnings per share over the last year. Alterola Biotech has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Wednesday, October 28th, 2020 based off prior year’s report dates.
Analyst Opinion on Alterola Biotech (OTCMKTS:ALTA)
1 Wall Street analysts have issued ratings and price targets for Alterola Biotech in the last 12 months. There are currently 1 buy rating for the stock, resulting in a consensus rating of “Buy.”
There is not enough analysis data for Alterola Biotech.
Dividend Strength: Alterola Biotech (OTCMKTS:ALTA)
Alterola Biotech pays a meaningful dividend of 2.28%, higher than the bottom 25% of all stocks that pay dividends. Alterola Biotech does not have a long track record of dividend growth.
Insiders buying/selling: Alterola Biotech (OTCMKTS:ALTA)
In the past three months, Alterola Biotech insiders have sold 160,455.89% more of their company’s stock than they have bought. Specifically, they have bought $433.00 in company stock and sold $695,207.00 in company stock.
Earnings and Valuation of Alterola Biotech (OTCMKTS:ALTA
More latest stories: here